{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:02:21Z","timestamp":1791331341196,"version":"4.3.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T00:00:00Z","timestamp":1597190400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods &amp; Clinical Development"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.omtm.2020.08.010","type":"journal-article","created":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T13:28:43Z","timestamp":1597411723000},"page":"1-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Lentiviral Vector Production from a Stable Packaging Cell Line Using a Packed Bed Bioreactor"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3068-6077","authenticated-orcid":false,"given":"Alicia D.","family":"Powers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason E.","family":"Drury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher F.","family":"Hoehamer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy D.","family":"Lockey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael M.","family":"Meagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2020.08.010_bib1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1146\/annurev-bioeng-071813-104938","article-title":"Viral vectors for gene therapy: translational and clinical outlook","volume":"17","author":"Kotterman","year":"2015","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/j.omtm.2020.08.010_bib2","doi-asserted-by":"crossref","first-page":"1233151","DOI":"10.1126\/science.1233151","article-title":"Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome","volume":"341","author":"Aiuti","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.omtm.2020.08.010_bib3","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1056\/NEJMoa1815408","article-title":"Lentiviral gene therapy combined with low-dose busulfan in infants with SCID-X1","volume":"380","author":"Mamcarz","year":"2019","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2020.08.010_bib4","doi-asserted-by":"crossref","first-page":"335ra57","DOI":"10.1126\/scitranslmed.aad8856","article-title":"Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiency","volume":"8","author":"De Ravin","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtm.2020.08.010_bib5","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/B978-0-12-386509-0.00010-7","article-title":"Lentiviral hematopoietic cell gene therapy for X-linked adrenoleukodystrophy","volume":"507","author":"Cartier","year":"2012","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.omtm.2020.08.010_bib6","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nature09328","article-title":"Transfusion independence and HMGA2 activation after gene therapy of human \u03b2-thalassaemia","volume":"467","author":"Cavazzana-Calvo","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2020.08.010_bib7","doi-asserted-by":"crossref","first-page":"1233158","DOI":"10.1126\/science.1233158","article-title":"Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy","volume":"341","author":"Biffi","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.omtm.2020.08.010_bib8","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","article-title":"Chimeric antigen receptor T\u00a0cells for sustained remissions in leukemia","volume":"371","author":"Maude","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2020.08.010_bib9","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s40259-017-0247-0","article-title":"Next-generation chimeric antigen receptor T-cell therapy: going off the shelf","volume":"31","author":"Ruella","year":"2017","journal-title":"BioDrugs"},{"key":"10.1016\/j.omtm.2020.08.010_bib10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jviromet.2008.11.021","article-title":"Simplified lentivirus vector production in protein-free media using polyethylenimine-mediated transfection","volume":"157","author":"Kuroda","year":"2009","journal-title":"J.\u00a0Virol. Methods"},{"key":"10.1016\/j.omtm.2020.08.010_bib11","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jviromet.2006.07.024","article-title":"Transfection of mammalian cells using linear polyethylenimine is a simple and effective means of producing recombinant adeno-associated virus vectors","volume":"138","author":"Reed","year":"2006","journal-title":"J.\u00a0Virol. Methods"},{"key":"10.1016\/j.omtm.2020.08.010_bib12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jbiotec.2016.10.016","article-title":"Challenges of up-scaling lentivirus production and processing","volume":"240","author":"McCarron","year":"2016","journal-title":"J.\u00a0Biotechnol."},{"key":"10.1016\/j.omtm.2020.08.010_bib13","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1089\/hgtb.2012.150","article-title":"Transduction of human CD34+ repopulating cells with a self-inactivating lentiviral vector for SCID-X1 produced at clinical scale by a stable cell line","volume":"23","author":"Greene","year":"2012","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.omtm.2020.08.010_bib14","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1089\/hgtb.2012.190","article-title":"RD2-MolPack-Chim3, a packaging cell line for stable production of lentiviral vectors for anti-HIV gene therapy","volume":"24","author":"Stornaiuolo","year":"2013","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.omtm.2020.08.010_bib15","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1089\/hgtb.2017.086","article-title":"Scalable lentiviral vector production using stable HEK293SF producer cell lines","volume":"28","author":"Manceur","year":"2017","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.omtm.2020.08.010_bib16","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.omtm.2019.11.011","article-title":"Production of lentiviral vectors using suspension cells grown in serum-free media","volume":"17","author":"Bauler","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2020.08.010_bib17","doi-asserted-by":"crossref","first-page":"16017","DOI":"10.1038\/mtm.2016.17","article-title":"Production of lentiviral vectors","volume":"3","author":"Merten","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2020.08.010_bib18","doi-asserted-by":"crossref","first-page":"20140040","DOI":"10.1098\/rstb.2014.0040","article-title":"Advances in cell culture: anchorage dependence","volume":"370","author":"Merten","year":"2015","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.omtm.2020.08.010_bib19","series-title":"Proceedings of the 21st Annual Meeting of the European Society for Animal Cell Technology (ESACT)","first-page":"719","article-title":"Poxvirus production on chicken embryo fibroblasts in iCELLis\u2122 disposable fixed-bed bioreactor","author":"Havelange","year":"2012"},{"key":"10.1016\/j.omtm.2020.08.010_bib20","first-page":"22","article-title":"Bioreactor design and bioprocess controls for industrialized cell processing","volume":"10","author":"Hambor","year":"2012","journal-title":"BioProcess Int."},{"key":"10.1016\/j.omtm.2020.08.010_bib21","series-title":"Proceedings of the 21st Annual Meeting of the European Society for Animal Cell Technology (ESACT)","first-page":"395","article-title":"On-line monitoring: animal cell cultivation in iCELLis\u2122 fixed-bed reactor using dielectric measurements","author":"Drugmand","year":"2012"},{"key":"10.1016\/j.omtm.2020.08.010_bib22","series-title":"Proceedings of the 21st Annual Meeting of the European Society for Animal Cell Technology (ESACT)","first-page":"375","article-title":"4 g\/L. day: monoclonal antibody volumetric productivity in the iCELLis\u2122 disposable fixed-bed bioreactor","author":"Drugmand","year":"2012"},{"key":"10.1016\/j.omtm.2020.08.010_bib23","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13568-014-0025-z","article-title":"Assessment of packed bed bioreactor systems in the production of viral vaccines","volume":"4","author":"Rajendran","year":"2014","journal-title":"AMB Express"},{"key":"10.1016\/j.omtm.2020.08.010_bib24","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/CJI.0000000000000072","article-title":"Large-scale clinical-grade retroviral vector production in a fixed-bed bioreactor","volume":"38","author":"Wang","year":"2015","journal-title":"J.\u00a0Immunother."},{"key":"10.1016\/j.omtm.2020.08.010_bib25","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1089\/hum.2015.081","article-title":"Process development of adenoviral vector production in fixed bed bioreactor: from bench to commercial scale","volume":"26","author":"Lesch","year":"2015","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2020.08.010_bib26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1753-6561-7-S6-P59","article-title":"Viral vector production in the Integrity>\u00ae iCELLis>\u00ae single-use fixed-bed bioreactor, from bench-scale to industrial scale","volume":"7","author":"Lennaertz","year":"2013","journal-title":"BMC Proc."},{"key":"10.1016\/j.omtm.2020.08.010_bib27","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1089\/hgtb.2016.021","article-title":"Development and optimization of AAV hFIX particles by transient transfection in an iCELLis>\u00ae fixed-bed bioreactor","volume":"27","author":"Powers","year":"2016","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.omtm.2020.08.010_bib28","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/biot.201500176","article-title":"Rational plasmid design and bioprocess optimization to enhance recombinant adeno-associated virus (AAV) productivity in mammalian cells","volume":"11","author":"Emmerling","year":"2016","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.omtm.2020.08.010_bib29","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/gt.2017.91","article-title":"Optimization of lentiviral vector production for scale-up in fixed-bed bioreactor","volume":"25","author":"Valkama","year":"2018","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2020.08.010_bib30","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.omtm.2019.08.006","article-title":"Preclinical proof-of-concept, analytical development, and commercial scale production of lentiviral vector in adherent cells","volume":"15","author":"Leinonen","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2020.08.010_bib31","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1089\/humc.2014.027","article-title":"Influence of mildly acidic pH conditions on the production of lentiviral and retroviral vectors","volume":"25","author":"Holic","year":"2014","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"10.1016\/j.omtm.2020.08.010_bib32","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/jcmm.12210","article-title":"Serum and supplement optimization for EU GMP-compliance in cardiospheres cell culture","volume":"18","author":"Chimenti","year":"2014","journal-title":"J.\u00a0Cell. Mol. Med."},{"key":"10.1016\/j.omtm.2020.08.010_bib33","doi-asserted-by":"crossref","first-page":"5104","DOI":"10.1182\/blood-2008-11-191049","article-title":"Efficient construction of producer cell lines for a SIN lentiviral vector for SCID-X1 gene therapy by concatemeric array transfection","volume":"113","author":"Throm","year":"2009","journal-title":"Blood"}],"container-title":["Molecular Therapy - Methods &amp; Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050120301765?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050120301765?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:23:23Z","timestamp":1762421003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050120301765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":33,"alternative-id":["S2329050120301765"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2020.08.010","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lentiviral Vector Production from a Stable Packaging Cell Line Using a Packed Bed Bioreactor","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2020.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors.","name":"copyright","label":"Copyright"}]}}